EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting B-Cell Receptor Signaling in Leukemia and Lymphoma: How and Why?

John C Allen, Fatima Talab, Joseph R Slupsky

International Journal of Hematologic Oncology · 2016

DOI: 10.2217/ijh-2016-0003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Hematologic Oncology, 2016. Verfasst von John C Allen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular & Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GE, UK. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 211 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B-lymphocytes are dependent on B-cell receptor (BCR) signaling for the constant maintenance of their physiological function, and in many B-cell malignancies this signaling pathway is prone to aberrant activation. This understanding has led to an ever-increasing interest in the signaling networks activated following ligation of the BCR in both normal and malignant cells, and has been critical in establishing an array of small molecule inhibitors targeting BCR-induced signaling. By dissecting how different malignancies signal through BCR, researchers are contributing to the design of more customized therapeutics which have greater efficacy and lower toxicity than previous therapies. This allows clinicians access to an array of approaches to best treat patients whose malignancies have BCR signaling as a driver of pathogenesis.

Schlagwörter

Stichwörter der Autor:innen

B-cell receptor signalingBruton's tyrosine kinaseMantle cell lymphomachronic lymphocytic leukemiadiffuse large B-cell lymphomafollicular lymphomaphosphoinositide 3-kinasespleen tyrosine kinase

Autor:innen und Institutionen

  • Department of Molecular & Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, L69 3GE, UK.
  • Redx Oncology Plc, Duncan Building, Royal Liverpool University Hospital, Daulby Street, Liverpool, L69 3GA, UK.
  • Department of Molecular & Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Ashton Street, Liverpool, L69 3GE, UK.

Zitieren

APA

Allen, J. C., Talab, F., & Slupsky, J. R. (2016). Targeting B-Cell Receptor Signaling in Leukemia and Lymphoma: How and Why?. International Journal of Hematologic Oncology. https://doi.org/10.2217/ijh-2016-0003

Vancouver

Allen JC, Talab F, Slupsky JR. Targeting B-Cell Receptor Signaling in Leukemia and Lymphoma: How and Why?. International Journal of Hematologic Oncology. 2016. doi:10.2217/ijh-2016-0003

BibTeX
@article{Allen2016,
  author = {Allen, John C and Talab, Fatima and Slupsky, Joseph R},
  title = {Targeting B-Cell Receptor Signaling in Leukemia and Lymphoma: How and Why?},
  journal = {International Journal of Hematologic Oncology},
  year = {2016},
  doi = {10.2217/ijh-2016-0003}
}
Kostenlos starten →